675 Safety and tolerability of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (RM-HNSCC)A. Dimitrios Colevas, Douglas Adkins, Venessa Chin et al.|Regular and Young Investigator Award Abstracts|2023Cited by 1